PF3644022 |
PF3644022 : ATP competitive inhibitor of MAPKAPK2
Probe Summary
Selectivity
Potency
In Vivo
Control Compounds
Chemical Information
References
Vendors
Download
Probe Summary
| Targets | Biochemical/Biophysical Potency | Cellular Potency |
|---|---|---|
| MAPKAPK2 |
|
|
ATP competitive
200-900 nM
Selectivity
In Vitro Selectivity Assessment
Potency: IC50 - MK3 53 nM, PRAK 53 nM, MNK2 148 nM, AMPK 117 nM, BrSK1 187 nM, BrSK2 90 nM, CAMK2 70 nM, DRAK1 71 nM, PIM1 88 nM, ASK1 60 nM, MER 76 nM
Potency Assay Off-Target:
At 1 uM, PF3644022 inhibited 16 kinases > 50% out of a panel of 200.
In Cell Selectivity Assessment
Selectivity Assessment Description:
PF36644022 did not interfere with the phosphorylation of substrates for p38alpha or JNK.
Potency Cellular
In Vitro
MAPKAPK2
Mode of Action: ATP competitive
Structure-Activity-Relationship data available? Yes
DOI Reference: 10.1124/jpet.110.166173
In Vivo Validations
Rat
Dose: 3 mg/kg
Route of delivery:
Oral
Plasma half life:
9.1 hr
Systemic clearance:
0.62 L/h/kg
DOI Reference: 10.1124/jpet.110.166173
Chemical Information
| Molecular Formula | C21H18N4OS |
| SMILEs | Cc1ccc(-c2ccc3c(ccc4sc5c(c43)NC[C@@H](C)NC5=O)n2)cn1 |
| InChI | InChI=1S/C21H18N4OS/c1-11-3-4-13(10-22-11)15-6-5-14-16(25-15)7-8-17-18(14)19-20(27-17)21(26)24-12(2)9-23-19/h3-8,10,12,23H,9H2,1-2H3,(H,24,26)/t12-/m1/s1 |
| Molecular weight | 374.12 Da |
| AlogP | 4.363720000000003 |
| HBond acceptors | 5 |
| HBond donors | 2 |
| Atoms | 45 |
Vendors
Note: This is not an exhaustive list and does not indicate endorsement by the portal.